Search
Seasonal influenza is an important cause of acute neurological disease in Australian children.
These findings reinforce current recommendations for annual influenza vaccination, particularly those at greatest risk of influenza disease.
A new research project aims to demonstrate how influenza vaccination in children could be a highly cost-effective health care intervention in Australia.
It's that time of year again... Flu vaccine time! Watch Dr Chris Blyth answer commonly asked questions in the video below.
In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.
Evidence is emerging of benefit to the infant with respect to preventing influenza infection in the first 6 months of life. The FluMum study aims to...
Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010.
The rapid diagnosis of influenza is critical in optimizing clinical management. Rapid antigen tests have decreased sensitivity in detecting pandemic influenza.
To assess the immunogenicity and safety of a 2009 influenza A(H1N1) vaccine in children.
Males are generally more susceptible to respiratory infections; however, there are few data on the physiological responses to such infections in males and...